Cutaneous Mucormycosis in Premature Newborn Babies: A Case Report
Abstract
Introduction: Mucormycosis is a serious infection cause by opportunist fungus, of the mucoral type, and results in high mortality. It is more frequent in immuno-suppressed patients and associated with debilitating diseases. One of the presentation forms is cutaneous. Case report: A premature newborn female, with 34 weeks of gestation, was admitted in the intensive care unit with hyaline membrane disease as the only concern. On the fifth day of hospitalization a purple round pointed lesion in the left cheek appeared that became a profound necrosis. Treatment began with imipenen, vancomicin, and amikacin, together with surgical debridement. Cultures and histo-pathological studies showed non-septate hyphae, and cultures identified Rhizopus sp. As soon as the culture results were available, additional treatment with amphotericin B 1.5 mg per Kg per day was initiated . The evolution of patient was satisfactory and she was released from the intensive care unit. Conclusion: We observed how important the immunological state of the patient is, and treatment must be aggressive, multidisciplinary and always oriented to each individual case.
Copyright (c) 2005 Betty Calabria O, Náyade Acosta A, Luís Gallegos L, Hernán Vargas Montiel
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Kasmera journal is registered under a Creative Commons an Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0), available at: https://creativecommons.org/licenses/by-nc-sa/4.0/deed.en; which guarantees the freedom to share-copy and redistribute the material in any medium or format and adapt-remix, transform and build from the material, provided that the name of the authors, the Department of Infectious and Tropical Diseases, Zulia´s University and Kasmera Journal, you must also provide a link to the original document and indicate if changes have been made.
The Department of Infectious and Tropical Diseases, University of Zulia and Kasmera Journal do not retain the rights to published manuscript and the contents are the sole responsibility of the authors, who retain their moral, intellectual, privacy and publicity rights. The guarantee on the intervention of the manuscript (revision, correction of style, translation, layout) and its subsequent dissemination is granted through a license of use and not through a transfer of rights, which represents the Kasmera Journal and Department Infectious Diseases, University of Zulia are exempt from any liability that may arise from ethical misconduct by the authors.
Kasmera is considered a green SHERPA/RoMEO journal, that is, it allows self-archiving of both the pre-print (draft of a manuscript) and the post-print (the corrected and peer-reviewed version) and even the final version (layout as it will be published in the journal) both in personal repositories and in institutional and databases.